InvestorsHub Logo
Followers 62
Posts 7498
Boards Moderated 1
Alias Born 01/02/2003

Re: Mr Stockboy post# 423399

Friday, 04/19/2024 8:48:09 AM

Friday, April 19, 2024 8:48:09 AM

Post# of 423945
"Amarin has secured a worldwide patent priority claim to a LYMPH-RELEASING composition of eicosapentaenoic acid ethyl ester (LR-EtEPA) technology/invention and methods of using the same to increase EPA uptake in tissues to treat and/or prevent the onset of a number of diseases including:
- Cardiopulmonary, cardiovascular, and cerebrovascular diseases
- Pulmonary disease including sepsis, SIRS, and/or ARDS
- Neurological diseases
- Cancer...including cancers associated with the lymphatic system"(e.g. LYMPHOMAS)

I would hope that some mention of this product will be made by CEO Holt at the Amarin upcoming Q4 2023 results C.C. on 5/2/24
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News